Kiboko Gold Inc. - Private Placement of 10,000,000 Units at $0.10 Each
Kiboko Gold Inc. - Consolidation on Basis of 1 for 10 Shares
Kiboko Announces Proposed Share Consolidation and Private Placement
Democratic BILL to Avert U.S. Government Shutdown Failing to Win Enough Votes to Pass in Senate; Voting Continues
Alphonso Inc. Announces Confidential Submission of Draft Registration Statement for Proposed Public Listing
Trilogy Metals Reports Third Quarter Fiscal 2025 Financial Results
Trilogy Metals Q3 Net Income USD -1.747 Million
New Zealand S/Adjusted New Dwelling Consents +5.8 Pct in Aug VS Pvs Month
Novartis Says Wholesesale Acquistion Cost of Rhapsido Is $4,521 per Package
Innocan Pharma Corp: NOW Sees IPO of 1.1 Mln Units - SEC Filing
Zooz Power Ltd: May Offer and Sell up to $1 Bln Ordinary Shares From Time to Time - SEC Filing
Global Sumud Flotilla: We Are on a High-Alert as Our Flotilla Reaches 10 Nautical Miles From the High Risk Zone.
Novartis Receives FDA Approval for Rhapsido® (Remibrutinib), the Only Oral, Targeted Btki Treatment for Chronic Spontaneous Urticaria (Csu)